HealthDay on MSN1d
Baseline Characteristics ID Risk for Recurrent Endoscopic Sinus Surgery
THURSDAY, Feb. 6, 2025 (HealthDay News) -- A few baseline characteristics can predict the need for recurrent endoscopic sinus ...
Asthma and antibiotic use may predict nasal polyp recurrence after endoscopic sinus surgery
The probability of revision sinus surgery including removing nasal polyps is higher if the patient has asthma or is on ...
GSK's depemokimab gets EMA nod for asthma and nasal polyps
GSK plc (LSE/NYSE: GSK), a prominent pharmaceutical company with a market capitalization of $71.29 billion and currently ...
GSK says asthma and nasal polyps therapy under EU review
GSK (GSK) stock in focus as its experimental drug depemokimab undergoes EU review for asthma and nasal polyps. Read more here ...